| Home > Finance News > > |
Earlier Headlines
- Securities and Exchange Commission (SEC) Clears Proxy Statement Filed by Activist Shareholder of Artes Medical, Inc. - Business Wire - Mon Oct 6, 10:49 AM
- Applied Biosystems, Amaxa, and Invitrogen Lead Attractive Gene Silencing Market - Revealed in New Life Science Dashboard(TM) Market Research Report - Business Wire - Mon Oct 6, 10:45 AM
- InnovationRx Launches Medication Adherence Awareness Campaign in California - Business Wire - Mon Oct 6, 10:32 AM
- HealthSport, Inc. Enters Into Exclusive Reseller Agreement With T. Lynn Mitchell Companies, LLC - PRNewswire - Mon Oct 6, 10:18 AM
- Provectus Lead Investigator Professor John F. Thompson Gives Update on PV-10 Phase 2 Study - Business Wire - Mon Oct 6, 10:18 AM
- A Weekly R&D Pipeline News Analysis - A Technology Edition Providing a Valuable Competitive Intelligence Tool for the Biopharmaceutical Industry - Business Wire - Mon Oct 6, 10:03 AM
- Don't Shelve the Sunblock - Sunburn Risk Can be Even Greater in Winter - PRNewswire - Mon Oct 6, 10:03 AM
- Exosome Diagnostics Announces That Roger Henriksson, M.D., Ph.D. is Joining its Scientific Advisory Board - PRNewswire - Mon Oct 6, 9:54 AM
- New England Research Institutes, Inc., Appoints Dr. Ramses F. Sadek to Vice President of Biometrics - Business Wire - Mon Oct 6, 9:49 AM
- CDEX Inc. Security Division Announces First Shipment to New Distributor in Japan - Business Wire - Mon Oct 6, 9:40 AM
- Malaysia Pharmaceuticals to Reach US$1.52bn by 2012, Which Is Slightly Less Than the Q208 Forecast of US$1.82bn - Business Wire - Mon Oct 6, 9:38 AM
- Reducing Health Care Costs Offers Real Opportunity for Venture Capitalists, Says ONSET Ventures - Business Wire - Mon Oct 6, 9:24 AM
- PhytoMedical Renews Sponsored Research Agreement with Dartmouth College - Business Wire - Mon Oct 6, 9:15 AM
- Blue Vector Selected by Global Pharma Manufacturer to Meet January 2009 Turkish Serialization Mandates - Business Wire - Mon Oct 6, 9:09 AM
- Urodynamix and Timm Medical Sign Development and Distribution Agreement - Marketwire - Mon Oct 6, 9:09 AM
- Salix Presents New Phase II Data Evidence Demonstrating the Clinical Utility of Rifaximin in Irritable Bowel Syndrome (IBS) - Business Wire - Mon Oct 6, 9:06 AM
Yahoo! Finance Videos
Interview with: Selwyn Resources Ltd.
CEOClips.com
- Interview with: Tyhee Development Corp.CEOClips.com
- Interview with: Rye Patch Gold Corp.CEOClips.com
- Interview with: Pelangio Exploration Inc./PDX Resources Inc.CEOClips.com
572.92 (5.30%)Today on Yahoo!
Top Stories
TSX plummets more than 1,200 points before rebound
The Canadian Press - TORONTO - A rally at the end of the day somewhat reduced earlier...
The Canadian Press - TORONTO - A rally at the end of the day somewhat reduced earlier...
Entertainment
Israeli 'Big Brother' TV show shuts down for Yom Kippur
The Canadian Press - NEVE ILAN, Israel - The television show "Big Brother" will confront a new...
The Canadian Press - NEVE ILAN, Israel - The television show "Big Brother" will confront a new...
Sports
Jets appeal Smith's suspension for hit on Boldin
AFP - FLORHAM PARK, New Jersey (AFP) - New York Jets Eric Smith is appealing a suspension for a...
AFP - FLORHAM PARK, New Jersey (AFP) - New York Jets Eric Smith is appealing a suspension for a...
advertisements
RSS Feeds
Add headlines to your personalized My Yahoo! page
(Learn about My Yahoo! and RSS)
- Finance News
- Add to My Yahoo! RSS
- Canadian Markets Headlines
- Add to My Yahoo! RSS
- U.S. Markets Headlines
- Add to My Yahoo! RSS
- International Markets Headlines
- Add to My Yahoo! RSS